<DOC>
	<DOCNO>NCT00123201</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety dronabinol MDI acute treatment moderate severe migraine headache .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Dronabinol Metered Dose Inhaler ( MDI ) Acute Treatment Migraine Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Male female subject 18 65 year , inclusive , clinically diagnose migraine without aura base International Headache Society criterion Subjects experience migraine prolong aura ; familiar hemiplegic migraine ; migrainous infarction basilar migraine ; great eight migraine attack per month and/or great 14 migraine day per month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>efficacy &amp; safety , migraine headache , placebo-controlled</keyword>
	<keyword>migraine headache without aura</keyword>
</DOC>